Riam Shammaa

Director/Miembro de la Junta en DEFENCE THERAPEUTICS INC. .

Health Technology

Perfil

Riam Shammaa is the founder of IntelliStem Technologies, Inc. where he holds the title of Chief Executive Officer since 2019.
Dr. Shammaa is also the founder of Pallianera Pharma, Inc. Dr. Shammaa's current job is as an Independent Director at Defence Therapeutics Inc since 2021.

Cargos activos de Riam Shammaa

Empresas	Cargo	Inicio
DEFENCE THERAPEUTICS INC.	Director/Miembro de la Junta	09/11/2021
IntelliStem Technologies, Inc. IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation.	Director Ejecutivo	04/02/2019

Todos los cargos activos de Riam Shammaa

Antiguos cargos conocidos de Riam Shammaa.

Empresas	Cargo	Fin
Pallianera Pharma, Inc.	Fundador	-

Ver el detalle de la experiencia de Riam Shammaa.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Riam Shammaa.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
DEFENCE THERAPEUTICS INC.	Health Technology

Empresas privadas	2
IntelliStem Technologies, Inc. IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation.	Health Technology
Pallianera Pharma, Inc.